Fri. Dec 2nd, 2022
USFDA cites CGMP violations at Panacea Biotec#39;s Baddi plant in warning letter In a letter to Panacea Biotec Managing Director Rajesh Jain, the USFDA said its inspectors, from February 10-20, 2020, found significant deviations from standard manufacturing practices at company#39;#39;s Baddi plant.